Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Gastroenterology Research and Practice|August 20, 2013
The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous UrticariaYi-Chun Chiu, Wei-Chen Tai, Seng-Kee Chuah, et al.
The American Journal of Pathology|December 11, 2012
Overexpression of Rap-1A indicates a poor prognosis for oral cavity squamous cell carcinoma and promotes tumor cell invasion via Aurora-A modulationChang-Han Chen, Hui-Ching Chuang, Chao-Cheng Huang, et al.
Cancer|September 26, 2003
Expression of hepatoma-derived growth factor in hepatocellular carcinomaTsung-Hui Hu, Chao-Cheng Huang, Li-Feng Liu, et al.
Angiogenesis|February 1, 2018
Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1/Akt/eNOS signaling in endothelial cellsChao-Cheng Huang, Hsiao-Mei Kuo, Pei-Chang Wu, et al.
Oncotarget|May 10, 2014
Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behaviorChih-Yen Chien, Hsin-Ting Tsai, Li-Jen Su, et al.
The Journal of Pathology|January 7, 2026
Delta-like 1 homolog (DLK1) regulates cancer stemness and chemoresistance of ovarian cancer by CD44/CD133 upregulationChao-Cheng Huang, Jian-Ching Wu, Pei-Chin Chen, et al.
Thyroid : Official Journal of the American Thyroid Association|April 22, 2010
miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutationChen-Kai Chou, Rong-Fu Chen, Fong-Fu Chou, et al.
Angiogenesis|May 12, 2018
Correction to: Soluble delta-like 1 homolog (DLK1) stimulates angiogenesis through Notch1/Akt/eNOS signaling in endothelial cellsChao-Cheng Huang, Hsiao-Mei Kuo, Pei-Chang Wu, et al.
BMC Cancer|August 22, 2018
The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapyYen-Hao Chen, Hung-I Lu, Chien-Ming Lo, et al.
Scientific Reports|May 4, 2017
Metformin disrupts malignant behavior of oral squamous cell carcinoma via a novel signaling involving Late SV40 factor/Aurora-AChang-Han Chen, Hsin-Ting Tsai, Hui-Ching Chuang, et al.
Pageof 21